Determinants of Sudden Cardiac Death in Patients With Persistent Atrial Fibrillation in the RAte Control Versus Electrical Cardioversion (RACE) Study

American Journal of Cardiology

Volumn 98, Issue 7, 2006, Pages 929-932

  Hagens, Vincent E ^a   Rienstra, Michiel ^a   Van Veldhuisen, Dirk J ^a   Crijns, Harry J G M ^b   Van Gelder, Isabelle C ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; FLECAINIDE; PHENPROCOUMON; SOTALOL;

ADULT; AGED; ARTICLE; CARDIOVERSION; CLINICAL TRIAL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HAZARD ASSESSMENT; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART RATE; HEART RHYTHM; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; STROKE; SUDDEN DEATH; UNSPECIFIED SIDE EFFECT;

ADRENERGIC BETA-ANTAGONISTS; AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CALCIUM CHANNEL BLOCKERS; DEATH, SUDDEN, CARDIAC; DIABETES MELLITUS; DIGITALIS GLYCOSIDES; ELECTRIC COUNTERSHOCK; FATIGUE; FEMALE; FLECAINIDE; FOLLOW-UP STUDIES; HUMANS; MALE; MYOCARDIAL INFARCTION; NETHERLANDS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RISK FACTORS; SOTALOL;

EID: 33748754377     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.04.038     Document Type: Article

References (18)

1. Zipes D.P., and Wellens H.J. Sudden cardiac death. Circulation 98 (1998) 2334-2351
2. Rubart M., and Zipes D.P. Mechanisms of sudden cardiac death. J Clin Invest 115 (2005) 2305-2315
3. Huikuri H.V., Castellanos A., and Myerburg R.J. Sudden death due to cardiac arrhythmias. N Engl J Med 345 (2001) 1473-1482
4. Uretsky B.F., Thygesen K., Armstrong P.W., Cleland J.G., Horowitz J.D., Massie B.M., Packer M., Poole-Wilson P.A., and Ryden L. Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial. Circulation 102 (2000) 611-616
5. Phillips L.H., Whisnant J.P., and Reagan T.J. Sudden death from stroke. Stroke 8 (1977) 392-395
6. Virmani R., Burke A.P., and Farb A. Sudden cardiac death. Cardiovasc Pathol 10 (2001) 211-218
7. Steinberg J.S., Sadaniantz A., Kron J., Krahn A., Denny D.M., Daubert J., Campbell W.B., Havranek E., Murray K., Olshansky B., et al. Analysis of cause-specific mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Circulation 109 (2004) 1973-1980
8. Van Gelder I.C., Hagens V.E., Bosker H.A., Kingma J.H., Kamp O., Kingma T., Said S.A., Darmanata J.I., Timmermans A.J., Tijssen J.G., and Crijns H.J.G.M. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 347 (2002) 1834-1840
9. The Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. Ann Intern Med 116 (1992) 1-5
10. The Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. Ann Intern Med 116 (1992) 6-12
11. Pedersen O.D., Abildstrom S.Z., Ottesen M.M., Rask-Madsen C., Bagger H., Kober L., and Torp-Pedersen C. Increased risk of sudden and nonsudden cardiovascular death in patients with atrial fibrillation/flutter following acute myocardial infarction. Eur Heart J 27 (2006) 290-295
12. The MERIT-HF Investigators. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353 (1999) 2001-2007
13. Solomon S.D., Zelenkofske S., McMurray J.J., Finn P.V., Velazquez E., Ertl G., Harsanyi A., Rouleau J.L., Maggioni A., Kober L., et al. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 352 (2005) 2581-2588
14. Gottlieb S.S., McCarter R.J., and Vogel R.A. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med 339 (1998) 489-497
15. Dargie H.J. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet 357 (2001) 1385-1390
16. Domanski M.J., Krause-Steinrauf H., Massie B.M., Deedwania P., Follmann D., Kovar D., Murray D., Oren R., Rosenberg Y., Young J., Zile M., and Eichhorn E. A comparative analysis of the results from 4 trials of beta-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUS. J Card Fail 9 (2003) 354-363
17. Joglar J.A., Acusta A.P., Shusterman N.H., Ramaswamy K., Kowal R.C., Barbera S.J., Hamdan M.H., and Page R.L. Effect of carvedilol on survival and hemodynamics in patients with atrial fibrillation and left ventricular dysfunction: retrospective analysis of the US Carvedilol Heart Failure Trials Program. Am Heart J 142 (2001) 498-501
18. Lechat P., Hulot J.S., Escolano S., Mallet A., Leizorovicz A., Werhlen-Grandjean M., Pochmalicki G., and Dargie H. Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial. Circulation 103 (2001) 1428-1433